Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Nov 21, 2025, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $298.05 million as of November 21, 2025. Its market cap has decreased by -64.60% in one year.
Market Cap
298.05M
Enterprise Value
196.04M
Revenue
25.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.60
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 298.05M, a decrease of -44.64%. That is a compound annual growth rate of -10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 298.05M | -8.25% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Elite Pharmaceuticals | 621.43M |
| Glass House Brands | 459.89M |
| American Oncology Network | 412.69M |
| Tian'an Technology Group | 385.99M |
| Northwest Biotherapeutics | 374.98M |
| CytoDyn | 372.76M |
| Nika Pharmaceuticals | 311.89M |